- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
13 result(s) found for: Intrauterine Growth Retardation.
Displaying page 1 of 1.
EudraCT Number: 2017-001905-33 | Sponsor Protocol Number: FSJD-TRACIP-2017 | Start Date*: 2017-10-25 | |||||||||||
Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
Full Title: TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN: RANDOMIZED CLINICAL TRIAL (TRACIP STUDY) | |||||||||||||
Medical condition: EARLY INTRAUTERINE GROWTH RESTRICTION | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000818-20 | Sponsor Protocol Number: 2009/318 | Start Date*: 2011-05-04 | |||||||||||
Sponsor Name:Klinisk Biokemisk Afdeling, Aarhus Universitetshospital, Skejby | |||||||||||||
Full Title: Kan behandling med lavmolekylært heparin under graviditet med intrauterin væksthæmning øge fostervæksten? | |||||||||||||
Medical condition: Intrauterin væksthæmning | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005398-32 | Sponsor Protocol Number: STRIDER | Start Date*: 2014-07-18 | |||||||||||
Sponsor Name:Liverpool Women's NHSFT [...] | |||||||||||||
Full Title: A randomised controlled trial of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction | |||||||||||||
Medical condition: Early onset intrauterine growth restriction | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003730-13 | Sponsor Protocol Number: OST07/11 | Start Date*: 2012-05-22 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||
Full Title: Effects of plasma expanders administration in pregnancies complicated by intra uterine growth restriction | ||||||||||||||||||
Medical condition: intra uterine growth restriction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003536-30 | Sponsor Protocol Number: PHRN08-FP-PERASTUN | Start Date*: 2012-05-07 | ||||||||||||||||
Sponsor Name:CHRU de TOURS | ||||||||||||||||||
Full Title: | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004160-38 | Sponsor Protocol Number: 93-8122-001 | Start Date*: 2015-04-01 |
Sponsor Name:KABI PHARMACIA S.A. | ||
Full Title: A 2 Year Multicenter Study of Genotropin Treatment of Short Prepubertal Children with Intra-Uterine Growth Retardation | ||
Medical condition: Growth Disorders, Intrauterine Growth Retardation | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2016-004396-51 | Sponsor Protocol Number: ZKS_0021PETN | Start Date*: 2017-06-26 | |||||||||||
Sponsor Name:Friedrich Schiller University | |||||||||||||
Full Title: Pentaerithrityl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction (PETN Trial) | |||||||||||||
Medical condition: Pregnant women at risk of adverse pregnancy outcome due to intrauterine growth retardation identified by impaired uterine Doppler measurements at mid gestation (19+0 - 22+6 weeks of gestation). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000424-25 | Sponsor Protocol Number: 1508175 | Start Date*: 2016-04-12 | |||||||||||||||||||||
Sponsor Name:CHU Saint-Etienne | |||||||||||||||||||||||
Full Title: Low-molecular-weight heparin in constituted vascular intrauterine growth restriction. Randomized multicenter trial | |||||||||||||||||||||||
Medical condition: Intrauterine growth restriction (IUGR) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000622-22 | Sponsor Protocol Number: ASAP | Start Date*: 2012-07-20 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Aspirin for the enhancement of trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks of gestation | |||||||||||||
Medical condition: Placental insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002095-17 | Sponsor Protocol Number: MAGSPET | Start Date*: 2011-09-13 | |||||||||||
Sponsor Name:Anna Suy Franch | |||||||||||||
Full Title: Sulfato de magnesio en pauta continua versus discontinua en la conducta expectante de la preeclampsia grave: ensayo clínico aleatorizado | |||||||||||||
Medical condition: Preeclampsia grave | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005031-32 | Sponsor Protocol Number: Diabetes2017 | Start Date*: 2017-10-10 | |||||||||||
Sponsor Name:Pirkanmaan sairaanhoitopiiri | |||||||||||||
Full Title: Metformin use to improve pregnancy outcome in women with type 1 diabetes. A double-blind placebo-controlled multicenter study. | |||||||||||||
Medical condition: Pregnancy of a women dealing with type 1 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001984-53 | Sponsor Protocol Number: ETHIG II | Start Date*: 2006-10-11 | |||||||||||
Sponsor Name:Friedrich-Schiller-Universität Jena | |||||||||||||
Full Title: Effectiveness of Dalteparin Therapy as Intervention in recurrent pregnancy loss | |||||||||||||
Medical condition: Pregnant women with a history of recurrent pregnancy loss, defined as: - 2 or more early (< 12 weeks of gestation) pregnancy losses or - 1 or more late (> 12 weeks of gestation) pregnancy loss | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001489-41 | Sponsor Protocol Number: P00003466 | Start Date*: 2018-07-02 | |||||||||||
Sponsor Name:Karolinska Universitetssjukhuset | |||||||||||||
Full Title: Radiation- and alkylator-free hematopoietic cell transplantation for bone marrow failure due to dyskeratosis congenita / telomere disease | |||||||||||||
Medical condition: Dyskeratosis congenita / telomere disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.